More About Our Semaglutide Program:
Is it approved by the FDA?
In June of 2021, the FDA approved Semaglutide for the chronic treatment of obesity. Semaglutide already has approval to treat Type 2 diabetics.
Possible Side Effects:
- Nausea
- Diarrhea
- Cramps
- Bloating/Constipation
These side effects are controlled by starting at a low dose and increasing gradually over 16 weeks. Other
medications may stay in your stomach longer and their affect could be
delayed.
Clients with Type 1 Diabetes, pregnant or nursing or have/had thyroid cancer are NOT candidates for Semaglutide.
Svelte Semaglutide – Price Menu
- $100 New Patient Consult
- Your visit includes:
- Doctor’s assessment
- Blood work (Initial Visit)
- Body composition analysis
- Blood pressure
- Order vial of Semaglutide
- Body composition analysis
- Blood pressure
- Order vial of Semaglutide
- Body composition analysis
- Blood pressure
- Order vial of Semaglutide
- Body composition analysis
- Blood pressure
- Order vial of Semaglutide